A Flagship Pioneering-backed biotechnology company pioneering Modified DNA as a new class of genetic medicines, combining programmable durability and redosability without permanent genome alteration.

I had my daughter in January 2026, so she is eligible for a Trump Accounts app with $1,000 in it. I downloaded the Trump ...

Serif Health (Serif) today unveiled a reimagined healthcare cost intelligence experience designed to help organizations move from pricing questions to actionable answers faster and more confidently.

The design's minimalist typography does a lot of lifting.

Yeti’s new logo swaps its name for various four-letter words. It’s a smart idea that also reveals the risks of minimalist ...

Now, get ready for what we can only hope is the final boss of gendered eating: Man Cereal. Before you ask, no, it’s not a ...

Still, in my immodest opinion, it ranks among the most scintillating gems of short writing ever created to head a consequential news story. It’s a headline. It may be the headline of the century. It ...

Platform data establish Modified DNA’s potential to overcome two of the barriers that have kept DNA from becoming a practical medicine: innate immune activation and inefficient nuclear access ...

Flagship Pioneering Inc. has announced the launch of Serif Biomedicines Inc., a biotechnology company pioneering modified DNA as a new class of medicines. Modified DNA brings together the best ...

Following Flagship's origination of generative protein and mRNA platforms, Serif is pioneering Modified DNA medicines to program the foundational information layer of biology Serif to present data at ...